Evidence map›Paper›PMID 32528411›Full record

ArticleFrontiers in endocrinology2020

Pituispheres Contain Genetic Variants Characteristic to Pituitary Adenoma Tumor Tissue.

Raitis Peculis, Ilona Mandrika, Ramona Petrovska, Rasma Dortane, Kaspars Megnis, Jurijs Nazarovs, Inga Balcere, Janis Stukens, Ilze Konrade, Valdis Pirags and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Architects of Pituitary Tumour Growth.Frontiers in endocrinology · 2022
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Raitis PeculisDepartment of Human Genetics and Molecular Medicine, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Ilona MandrikaDepartment of Human Genetics and Molecular Medicine, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Ramona PetrovskaDepartment of Human Genetics and Molecular Medicine, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Rasma DortaneDepartment of Human Genetics and Molecular Medicine, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Kaspars MegnisDepartment of Human Genetics and Molecular Medicine, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Jurijs NazarovsDepartment of Pathology, Pauls Stradiņš Clinical University Hospital, Riga, Latvia.
Inga BalcereDepartment of Endocrinology, Riga East Clinical University Hospital, Riga, Latvia.
Janis StukensDepartment of Neurosurgery, Pauls Stradiņš Clinical University Hospital, Riga, Latvia.
Ilze KonradeDepartment of Human Genetics and Molecular Medicine, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Valdis PiragsClinic of Internal Medicine, Pauls Stradiņš Clinical University Hospital, Riga, Latvia.
Janis KlovinsDepartment of Human Genetics and Molecular Medicine, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Vita RoviteDepartment of Human Genetics and Molecular Medicine, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Latvian Biomedical Research and Study Centre · LVPauls Stradiņš Clinical University Hospital · LVRiga Stradiņš University · LV

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The most common type of pituitary neoplasms is benign pituitary adenoma (PA). Clinically significant PAs affect around 0.1% of the population. Currently, there is no established human PA cell culture available and when PA tumor cells are cultured they form two distinct types depending on culturing conditions either free-floating aggregates also known as pituispheres or cells adhering to the surface of cell plates and displaying mesenchymal stem-like properties. The aim of this study was to trace the origin of sphere-forming and adherent pituitary cell cultures and characterize the potential use of these surgery derived cell lines as PA model. We carried out a paired-end exome sequencing of patients' tumor and germline DNA using Illumina NextSeq followed by characterization of corresponding PA cell cultures. Variation analysis revealed a low amount of somatic mutations (mean = 5.2, range 3-7) in exomes of PAs. Somatic mutations of the primary surgery material can be detected in the exomes of respective pituispheres, but not in exomes of respective mesenchymal stem-like cells. For the first time, we show that the genome of pituispheres represents genome of PA while mesenchymal stem cells derived from the PA tissue do not contain mutations characteristic to PA in their genome, therefore, most likely representing normal cells of pituitary or surrounding tissues. This finding indicates that pituispheres can be used as a human model of PA cells, but combination of cell culturing techniques and NGS needs to be employed to adjust for disability to propagate spheres in culturing conditions.

Indexed as

Gene Expression Regulation, NeoplasticMutationAdenomaAdultBiomarkers, TumorExomeFollow-Up StudiesHumansMiddle AgedPituitary GlandPituitary NeoplasmsPrognosisTumor Cells, CulturedBiomarkers, Tumorpituispherespituitary adenomapituitary adenoma culturestumor sequencingwhole exome sequencing

Identifiers

PMID32528411
PMCPMC7256168
OpenAlexW3027836699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.